Literature DB >> 21719187

Association between cytokine gene polymorphisms and cervical cancer in a Chinese population.

Qian Wang1, Chenhua Zhang, Shah Walayat, Hong Wei Chen, Yili Wang.   

Abstract

OBJECTIVES: It has been hypothesized that inherited cytokine gene polymorphisms could influence susceptibility to cervical cancer. This study evaluated the association between tumour necrosis factor-alpha (TNF-α)-308, transforming growth factor-beta 1 (TGF-β1), interferon-gamma (IFN-γ)+874 and interleukin-10 (IL-10)-1082 gene polymorphisms and cervical cancer risk. STUDY
DESIGN: The study population included 186 histopathologically confirmed cases of cervical cancer and 200 healthy controls. TNF-α, TGF-β, IL-10 and IFN-γ gene polymorphisms were genotyped by polymerase chain reaction with sequence-specific primers.
RESULTS: The IFN-γ+874A/A genotype was associated with high risk for the development of cervical cancer [odds ratio (OR) 2.22, p=0.012], and the A allele was associated with a 1.47-fold increased risk of cervical cancer (p=0.009). In contrast, no significant difference was found in the frequencies of TNF-α-308G/A, TGF-β1 codons 10 and 25 C/C-G/G and IL-10-1082G/A gene polymorphisms between patients with cervical cancer and healthy controls.
CONCLUSIONS: Homozygous IFN-γ+874A/T polymorphisms may be associated with increased risk for the development of cervical cancer.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719187     DOI: 10.1016/j.ejogrb.2011.05.019

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  19 in total

1.  Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer.

Authors:  Lanling Wang; Kunpeng Ma; Zhiyong Wang; Yingying Mou; Li Ma; Yong Guo
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis.

Authors:  Yifan Sun; Yu Lu; Qiliu Pen; Taijie Li; Li Xie; Yan Deng; Aiping Qin
Journal:  Tumour Biol       Date:  2015-02-04

3.  IFN-γ +874 T/A polymorphisms contributes to cervical cancer susceptibility: a meta-analysis.

Authors:  Nannan Liu; Yan Song; Weifeng Shi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Zhaojun Shen; Xiaoli Hu; Luzhe Sun; Xueqiong Zhu
Journal:  Tumour Biol       Date:  2016-03-24

5.  Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis.

Authors:  Yu-Zheng Ge; Yi-Dan Wang; Zheng Xu; Lu-Wei Xu; Ya-Ping Wang; Mao-Hong Gu; Ai-Xing Ding; Xian-Bo Zhu; Ran Wu; Wen-Cheng Li; You-Di Xu; Rui-Peng Jia
Journal:  Tumour Biol       Date:  2014-03-28

6.  Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.

Authors:  Pallavi Singhal; Anoop Kumar; Soham Bharadwaj; Showket Hussain; Mausumi Bharadwaj
Journal:  Tumour Biol       Date:  2014-11-21

7.  A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer.

Authors:  Hua-Lian Zhang; Yi-Jie Zhang
Journal:  Tumour Biol       Date:  2013-03-15

8.  Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis.

Authors:  Min Li; Ying Han; Ting-Ting Wu; Yichen Feng; Hong-Bo Wang
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Circulating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects.

Authors:  Kai Qu; Qing Pang; Ting Lin; Li Zhang; Mingliang Gu; Wenquan Niu; Chang Liu; Ming Zhang
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

10.  Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations.

Authors:  Marcos A T Amador; Giovanna C Cavalcante; Ney P C Santos; Leonor Gusmão; João F Guerreiro; Ândrea Ribeiro-dos-Santos; Sidney Santos
Journal:  BMC Res Notes       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.